Toronto, ON -- (SBWIRE) -- 04/17/2012 -- Platinum Account Group can see that the healthcare and biotechnology remained the least affected sector from the recent global economic recession. Something like this is very impressive because the global economic recession has affected almost all the industries around the world. In fact, several of the major biotech companies quickly overcame and kicked back from the recessionary impact, and post positive gains. Biotech research growth in pharmaceutical operations, agriculture environmental monitoring, forensics, and animal husbandry sectors, continues to show strong and healthy development on the biotechnology instrumentation sector.

Platinum Account Group believes if there is a growth in the biotechnology instrumentation market, meaning there is also an increase in the number of research projects and in addition to this, the growth will also be filled up by the surging worldwide demand for innovative drugs and therapies, which in turn is driving the growth of the drug discovery research.

Over the next few years, Platinum Account Group is expecting that the market for biotechnology instrumentation will see a strong growth with the biotech and pharmaceutical companies seeking more cultivated and detailed analysis.